India's First Integrated Digital Accelerator

CRISPR Therapeutics Sectors, Funding and Contact Details

Cambridge, Massachusetts, United States

CRISPR Therapeutics

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Status

Independent

Sectors

• Biopharma • Biotechnology • Genetics • Medical

Employees

Founders

Chad Cowan, Craig Mello, Daniel Anderson, Emmanuelle Charpentier, Matthew Porteus, Rodger Novak, Shaun Foy

Last Funding

12/14/2020

Listed/Private

Public

Funding Stage

Size

Founded

January 1, 2013

Investors

New Enterprise Associates, Franklin Templeton Investments, Versant Ventures, Abingworth, Vertex Pharmaceuticals

Acquisitions

Ticker

CRSP

Study your competition to stay ahead